![Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/04/20/2021.04.14.21255503/F14.large.jpg)
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv
![Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis - The Lancet Public Health Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis - The Lancet Public Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fbbf54ba-9eba-4f87-9454-0d24deb50249/gr1_lrg.jpg)
Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis - The Lancet Public Health
![Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland - The Lancet Regional Health – Europe Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland - The Lancet Regional Health – Europe](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/ce037308-6004-4e36-b1e8-bc5c02025672/gr1.jpg)
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland - The Lancet Regional Health – Europe
![Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/04/20/2021.04.14.21255503/F4.large.jpg)
Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland | medRxiv
![Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies | BMJ Open Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/8/3/e017806/F1.large.jpg)
Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies | BMJ Open
![A survey on what pharmacists and physicians caring for nursing home residents expect of user-friendly lists of potentially inappropriate prescribing (PIP lists) - Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen A survey on what pharmacists and physicians caring for nursing home residents expect of user-friendly lists of potentially inappropriate prescribing (PIP lists) - Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cbbaa239-d0a5-4810-a785-433c4027b1a3/gr1_lrg.jpg)
A survey on what pharmacists and physicians caring for nursing home residents expect of user-friendly lists of potentially inappropriate prescribing (PIP lists) - Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen
![Survival analysis as a statistical methodology for analyzing factors that affect milk coagulation time in Holstein-Friesian and Brown Swiss cows - Journal of Dairy Science Survival analysis as a statistical methodology for analyzing factors that affect milk coagulation time in Holstein-Friesian and Brown Swiss cows - Journal of Dairy Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ba930e14-3fe2-49d6-9998-b8048a666da6/gr1_lrg.jpg)
Survival analysis as a statistical methodology for analyzing factors that affect milk coagulation time in Holstein-Friesian and Brown Swiss cows - Journal of Dairy Science
![Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study - European Journal of Cancer Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d20f58a5-1728-49dc-80b8-f48458fdca2c/fx1_lrg.jpg)
Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study - European Journal of Cancer
![SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing | medRxiv SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2021/02/12/2021.02.11.21251589/F2.large.jpg)
SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of October 2020 to February 2021 – implementation of Swiss-wide diagnostic screening and whole genome sequencing | medRxiv
![Temporal trends in legionellosis national notification data and the effect of COVID-19, Switzerland, 2000- 2020 | medRxiv Temporal trends in legionellosis national notification data and the effect of COVID-19, Switzerland, 2000- 2020 | medRxiv](https://www.medrxiv.org/content/medrxiv/early/2022/01/21/2022.01.19.22269395/F1.large.jpg)
Temporal trends in legionellosis national notification data and the effect of COVID-19, Switzerland, 2000- 2020 | medRxiv
![Bombesin, Bradykinin, Vasopressin, and Phorbol Esters Rapidly and Transiently Activate Src Family Tyrosine Kinases in Swiss 3T3 Cells - Journal of Biological Chemistry Bombesin, Bradykinin, Vasopressin, and Phorbol Esters Rapidly and Transiently Activate Src Family Tyrosine Kinases in Swiss 3T3 Cells - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/58c3830f-3b9d-4ade-9b59-c5a097e0f312/gr1.jpg)